Cellectar Biosciences, Inc. (NASDAQ:CLRB)
Cellectar Biosciences, Inc. (NASDAQ:CLRB) represented a move of 0 percent or $0 per share and closed its previous day trading session at $2.25. 0 Shares were traded in the last trading session with an Average Volume of 226.32 Million Shares. The stock currently has a Market Capitalization of 10.8 Million.
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
The stock traded between $ 2.02 and $15.90 over 1-Year time period showing its price to sales ratio of 0. Cellectar Biosciences, Inc. (NASDAQ:CLRB) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-13.21 and 200-Day Simple Moving Average of $-66.38. Its Price to Free Cash Flow is 0 and Price to Book of 0.54.
Analyst’s recommended the stock as 1.5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Cellectar Biosciences, Inc. (NASDAQ:CLRB) reported its Actual EPS of $-1.65/share. The analysts offering Earnings Estimates for the company were believing that Cellectar Biosciences, Inc. could bring EPS of $-0.83/share. The difference between Actual EPS and Estimated EPS was -0.82 Percent. Thus showing an Earnings Surprise of -98.8 Percent.
Orchids Paper Products Company (NYSE:TIS)
In the last trading session, Orchids Paper Products Company (NYSE:TIS) added its value by 0% closing at the price of $1.4. The stock currently has market capitalization of 15.98 Million, with average volume of 507.32 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Orchids Paper Products Company (NYSE:TIS) is showing beta of 2.1. This particular value of beta suggests that Orchids Paper Products Company (NYSE:TIS) has historically moved 210% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Orchids Paper Products Company (NYSE:TIS) is at $-2.56.
The stock currently has RSI of 44.56. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Orchids Paper Products Company is a tissue paper company that manufacturers and converts tissue product for the private label consumer market.
Orchids Paper Products Company (NYSE:TIS) topped its 52-week high price of $15.74 on 01/29/18 and 52-Week Low Price of $ 0.60 on 11/20/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 25.06% and monthly volatility of 22.43% respectively.